SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Andersen Lars L.)
 

Sökning: WFRF:(Andersen Lars L.) > The 'wise list'- a ...

  • Gustafsson, Lars L.Karolinska Institutet (författare)

The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm

  • Artikel/kapitelEngelska2011

Förlag, utgivningsår, omfång ...

  • 2011-03-18
  • Copenhagen :Blackwell Publishing,2011
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-81155
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-81155URI
  • https://doi.org/10.1111/j.1742-7843.2011.00682.xDOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:122179069URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • The aim was to present and evaluate the impact of a comprehensive strategy over 10 years to select, communicate and achieve adherence to essential drug recommendations (EDR) in ambulatory care in a metropolitan healthcare region. EDRs were issued and launched as a 'Wise List' by the regional Drug and Therapeutics Committee in Stockholm. This study presents the concept by: (i) documenting the process for selecting, communicating and monitoring the impact of the 'Wise List'; (ii) analysing the variation in the number of drug substances recommended between 2000 and 2010; (iii) assessing the attitudes to the 'Wise List' among prescribers and the public; (iv) evaluating the adherence to recommendations between 2003 and 2009. The 'Wise List' consistently contained 200 drug substances for treating common diseases. The drugs were selected based on their efficacy, safety, suitability and cost-effectiveness. The 'Wise List' was known among one-third of a surveyed sample of the public in 2002 after initial marketing campaigns. All surveyed prescribers knew about the concept and 81% found the recommendations trustworthy in 2005. Adherence to recommendations increased from 69% in 1999 to 77% in 2009. In primary care, adherence increased from 83% to 87% from 2003 to 2009. The coefficient of variation (CV%) decreased from 6.1% to 3.8% for 156 healthcare centres between these years. The acceptance of the 'Wise List' in terms of trust among physicians and among the public and increased adherence may be explained by clear criteria for drug recommendations, a comprehensive communication strategy, electronic access to recommendations, continuous medical education and involvement of professional networks and patients.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Wettermark, BjörnDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden; Regional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (författare)
  • Godman, BrianKarolinska Institutet (författare)
  • Andersén-Karlsson, EvaKarolinska Institutet (författare)
  • Bergman, UlfKarolinska Institutet (författare)
  • Hasselström, JanKarolinska Institutet (författare)
  • Hensjö, Lars-OlofInera Ltd., National Information Services for Swedish Healthcare, Stockholm, Sweden (författare)
  • Hjemdahl, PaulKarolinska Institutet (författare)
  • Jägre, IngridRegional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (författare)
  • Julander, MargarethaRegional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (författare)
  • Ringertz, BoDivision of Rheumatology, Department of Medicine, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden (författare)
  • Schmidt, DanielDepartment of Internal Medicine, St Göran Hospital, Stockholm, Sweden (författare)
  • Sjöberg, SusanKarolinska Institutet (författare)
  • Sjöqvist, FolkeKarolinska Institutet (författare)
  • Stiller, Carl-OlavKarolinska Institutet (författare)
  • Törnqvist, ElisabethRegional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (författare)
  • Tryselius, RolfRegional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (författare)
  • Vitols, SigurdClinical Pharmacology Services, Karolinska University Hospital, Stockholm, Sweden; Clinical Pharmacology Unit, Department of Medicine, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden (författare)
  • von Bahr, ChristerSection of Clinical Pharmacology, Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden (författare)
  • Regional Drug Expert Consortium, - (författare)
  • von Euler, Mia,1967-(författare)
  • Karolinska InstitutetDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden; Regional Drug and Therapeutics Committee, Medical Knowledge Centre, Stockholm County Council (Healthcare Region), Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Basic & Clinical Pharmacology & ToxicologyCopenhagen : Blackwell Publishing108:4, s. 224-2331742-78351742-7843

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy